A year and a half into the pandemic, the long-term effects of SARS-CoV-2 infection are garnering more research attention as millions of long COVID patients emerge.
CDC investigators continue to search for the source of the bacteria that caused four infections—two of them lethal—in four different states. The Scientist spoke with melioidosis expert Bart Currie about the disease.
The makers of the CRISPR-based testing platform, called miSHERLOCK, say it could enable people at home or physicians in resource-limited environments to detect SARS-CoV-2—and eventually, other pathogens.
The Scientist Creative Services Team | Jul 13, 2021
Richard Webby and Edward Hutchinson discuss influenza viruses—the development of new strains, how they mediate virulence, and their threat to human society.
As a result of massive summer gatherings in and around Cape Cod, hundreds of vaccinated people tested positive for COVID-19 with viral titers similar to unvaccinated patients.
Lateral flow tests for COVID-19 can be very accurate and specific when used as directed, but introducing acidic fluids can cause the tests’ detecting antibodies to clump, which may read as a positive result.
The resurfaced conversation surrounding the idea that SARS-CoV-2 might have leaked from a lab in Wuhan, China, represents an opportunity to reexamine the confluence of science, politics, and public discourse.
